valsartan has been researched along with Asymptomatic Conditions in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooksbank, KJM; Campbell, RT; Docherty, KF; Dreisbach, JG; Forsyth, P; Godeseth, RL; Hopkins, T; Jackson, AM; Jhund, PS; Lee, MMY; McConnachie, A; McMurray, JJV; Petrie, MC; Roditi, G; Squire, IB; Stanley, B; Welsh, P | 1 |
| Alves, C; Carballo, S; Darbellay, P; Lebowitz, D; Moret, M; Sabeh, N | 1 |
2 other study(ies) available for valsartan and Asymptomatic Conditions
| Article | Year |
|---|---|
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction.
Topics: Aged; Aminobutyrates; Asymptomatic Diseases; Biomarkers; Biphenyl Compounds; Disease Susceptibility; Drug Combinations; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Neprilysin; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Valsartan; Ventricular Dysfunction, Left; Ventricular Remodeling | 2021 |
[Internal medicine in the hospital setting].
Topics: Adrenergic beta-Antagonists; Aminobutyrates; Angiotensin Receptor Antagonists; Asymptomatic Diseases; Atrial Fibrillation; Biphenyl Compounds; Carotid Stenosis; Colchicine; Diuretics; Drug Combinations; Heart Failure; Hospitals; Humans; Internal Medicine; Liver Cirrhosis; Narcotics; Neprilysin; Pericarditis; Peritonitis; Pulmonary Disease, Chronic Obstructive; Respiratory Therapy; Spironolactone; Stroke; Tetrazoles; Valsartan | 2015 |